High-value research of 2014 presented for pulmonary med

May 9, 2015
High-value research of 2014 presented for pulmonary med

(HealthDay)—Articles relating to diffuse parenchymal lung disease, asthma, chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary diagnostics, and respiratory infections are included in a special update summary published online April 30 in the Annals of Internal Medicine.

Jess Mandel, M.D., from the University of California in San Diego, identified key studies published in 2014 that are highly relevant to the practice of pulmonary medicine.

Mandel included articles discussing beneficial therapies for , which had previously eluded effective treatment. Another study described a select group of patients with severe asthma refractory to traditional therapies who may benefit from a monoclonal antibody-based therapy. For COPD, one trial demonstrated that inhaled corticosteroids may be withdrawn from treatment of some patients with stable disease, while a second trial demonstrated that azithromycin most effectively decreases acute exacerbations that necessitate antibiotics and glucocorticoids in certain subsets of patients. Low-dose computed tomography screening was reported to be cost-effective for screening in appropriate patient groups. High sensitivity and specificity were reported in a meta-analysis of point-of-care ultrasonography for the diagnosis of acute cardiogenic pulmonary edema, when experienced operators perform the test. Finally, oseltamivir was found to be modestly effective for influenza treatment in adults, although adverse events were reported.

"This article summarizes important studies published in 2014 that have the potential to substantially influence the practice of pulmonary and internal medicine," Mandel writes.

Mandel disclosed financial ties to the medical publishing industry.

Explore further: High-value research of 2014 presented for internal medicine

More information: Full Text (subscription or payment may be required)

Related Stories

High-value research of 2014 presented for internal medicine

May 4, 2015
(HealthDay)—Articles relating to atrial fibrillation, venous thromboembolism, acute bronchitis, ambulatory blood pressure monitoring for hypertension screening, and guidelines relevant to generalist practice are included ...

High-value research of 2014 presented for peri-op medicine

May 7, 2015
(HealthDay)—Articles relating to perioperative cardiac medicine, perioperative β-blocker use, perioperative pulmonary medicine, venous thromboembolism prophylaxis, and perioperative medication management are included in ...

High-value research of 2014 presented for geriatric medicine

May 5, 2015
(HealthDay)—Articles relating to overtreatment of cardiovascular disease, osteoporosis, and dementia care, as well as reduction of polypharmacy and adverse drug effects, are included in a special update summary published ...

High-value research of 2014 presented for gastroenterology

May 6, 2015
(HealthDay)—Articles relating to esophageal diseases, pancreatic cancer, colorectal cancer, inflammatory bowel disease, liver disease, and other topics are included in a special gastroenterology and hepatology update summary ...

Vitamin A receptor may help protect lungs from smoking, viral infections

May 8, 2015
It's no surprise that smoking is bad for the lungs. But only 10%-20% of long-term smokers will develop serious conditions that affect breathing, such as emphysema and chronic obstructive pulmonary disease (COPD). To understand ...

High-value research of 2014 presented for hematology

May 8, 2015
(HealthDay)—Articles relating to malignant hematology, transfusion medicine, and bleeding and clotting disorders are included in a special update summary published online April 30 in the Annals of Internal Medicine.

Recommended for you

Deadly Rift Valley fever: New insight, and hope for the future

July 19, 2018
Health control measures alone could be ineffective in the long term fight against the deadly Rift Valley fever which affects both humans and animals, a new study in the journal PNAS reports.

Yeast species used in food industry causes disease in humans

July 19, 2018
A major cause of drug-resistant clinical yeast infections is the same species previously regarded as non-pathogenic and commonly used in the biotechnology and food industries. The study, published on July 19th in the open-access ...

New guidelines to diagnose, manage rare endocrine disorders

July 19, 2018
International guidelines have been published for the first time to help doctors around the globe diagnose and manage patients with a very rare set of endocrine diseases known as pseudohypoparathyroidism and its related disorders, ...

Overuse of antibiotics not what the doctor ordered

July 19, 2018
With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community ...

Alcohol-related cirrhosis deaths skyrocket in young adults

July 18, 2018
Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

Childhood abuse linked to greater risk of endometriosis, study finds

July 17, 2018
Endometriosis, a painful condition that affects one in 10 reproductive-age women in the U.S., has been linked to childhood physical and sexual abuse, according to findings published today in the journal Human Reproduction.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.